golimumab-sldi

golimumab-sldi (IMMGOLIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: solution. Current US regulatory status: approved.

IMMGOLIS is a marketed brand name for golimumab-sldi. Check FDA Drugs@FDA for the current US label holder and prescribing information.

golimumab-sldi has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.